MedPath

Motric Bio

Ownership
Private
Employees
-
Market Cap
-
Website

Study of the Oral Treatment MTR-601 in Cervical Dystonia

Phase 2
Recruiting
Conditions
Cervical Dystonia
Interventions
Drug: Placebo
First Posted Date
2025-02-17
Last Posted Date
2025-05-16
Lead Sponsor
Motric Bio
Target Recruit Count
80
Registration Number
NCT06830642
Locations
🇺🇸

Keck Medicine of University of Southern California, Los Angeles, California, United States

🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

🇺🇸

Arizona Neuroscience Research, LLC, Phoenix, Arizona, United States

and more 7 locations

Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals

Phase 1
Completed
Conditions
Multiple Sclerosis
Spinal Cord Injuries
Cerebral Palsy
Stroke
Dystonia
Hypertonia, Muscle
Muscle Spasticity
Hereditary Spastic Paraplegia
Interventions
First Posted Date
2023-11-03
Last Posted Date
2025-03-12
Lead Sponsor
Motric Bio
Target Recruit Count
89
Registration Number
NCT06117020
Locations
🇺🇸

Worldwide Clinical Trials, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath